ClinicalTrials.govpublic full text
Is Spironolactone Safe and Effective in the Treatment of Cardiovascular Disease in Mild Chronic Renal Failure?
chronic kidney disease, cardiovascular disease, aldosterone, spironolactone, arterial stiffness, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 802927
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.